埃索美拉唑进医保没呢？

Esomeprazole (Nexium) is manufactured by AstraZeneca Pharmaceuticals Co., Ltd. Its active ingredient, esomeprazole magnesium, is the S-isomer of omeprazole. It reduces gastric acid secretion through a specific targeting mechanism and is a specific inhibitor of proton pumps in parietal cells. On July 30, 2020, AstraZeneca announced that the China National Medical Products Administration (NMPA) officially approved esomeprazole (Nexium) injection for the prevention of stress ulcer bleeding in severe patients.

The purpose of the clinical trial is to analyze the clinical effect of esomeprazole (Nexium) in the treatment of peptic ulcer. Experimental method: 86 patients with peptic ulcer treated in our hospital from February 2015 to February 2018 were randomly divided into a treatment group and a control group, and were treated with esomeprazole (Nexium) and omeprazole respectively. The trial analyzes the efficacy of the two groups and compares the symptom scores at different periods of treatment. Results: The total effective rate of the esomeprazole treatment group was 93.02%. The symptom score for 1 week of treatment was 3.72 points, the symptom score for 4 weeks of treatment was 2.26 points, and the symptom score for 8 weeks of treatment was 1.46 points. Compared with the omeprazole treatment group, the differences were statistically significant (P less than 0.05). Trial conclusion: Esomeprazole (Nexium) has significant clinical effect in treating peptic ulcer.

Esomeprazole has remarkable therapeutic effects, but is esomeprazole included in medical insurance?

Esomeprazole (Nexium) has entered the national medical insurance (2017 version), drug categories: drugs for the digestive tract and metabolism, drugs for the treatment of gastric acid-related diseases, drugs for the treatment of peptic ulcer disease and gastroesophageal reflux disease, proton pump inhibitors.

Medical Travel learned that the Indian version of esomeprazole (Nexium) is the cheapest, with a box costing about 500.